Background: Influenza viruses evolve rapidly and undergo immune driven selection, especially in the hemagglutinin (HA) protein. We report amino acid changes affecting antigenic epitopes and receptor-binding sites of A(H3N2) viruses circulating in Kilifi, Kenya, from 2009 to 2017. Methods: Next-generation sequencing (NGS) was used to generate A(H3N2) virus genomic data from influenza-positive specimens collected from hospital admissions and health facility outpatients presenting with acute respiratory illness to health facilities within the Kilifi Health and Demographic Surveillance System. Full-length HA sequences were utilized to characterize A(H3N2) virus genetic and antigenic changes.
| INTRODUC TI ON
Seasonal influenza viruses infect 5%-15% of the global population annually, resulting in 290 000-650 000 deaths each year. 1, 2 The disease burden is highest in developing countries especially in sub-Saharan Africa, [3] [4] [5] where influenza viruses may circulate year-round without clear seasonality; this is in contrast to the clear seasonality observed in temperate climatic regions. 6 Safe influenza vaccines exist, 1 but effectiveness depends on host immune responses and how well the vaccine strains match the strains in circulation. 7 Vaccine effectiveness can be low when there is a mismatch between vaccine selected strains and circulating viruses. 8 Influenza A viruses (IAV) cause the majority of influenza-associated disease burden and are further classified into subtypes based on the combination of their hemagglutinin (HA) and neuraminidase (NA) surface glycoproteins. 1 IAV, especially A(H3N2) virus, evolve rapidly and undergo immune driven selection. 9 This occurs through changes in viral antigenic epitopes that result in evasion of immune recognition and mainly involves mutations in the HA and NA gene segments. 10, 11 The HA glycoprotein is the primary target of host neutralizing antibodies, which inhibit the binding of HA to sialic acid receptors present on epithelial cell membranes of the upper respiratory tract. 12 Influenza A(H3N2) virus HA possesses defined antigenic epitopes (five sites designated A through E) and receptor-binding sites. 13 Accumulation of mutations at these antigenic sites results in viral escape from the host immune response. 14, 15 These sequence drifts on the HA from accumulated mutations are observed more frequently in A(H3N2) virus than A(H1N1) virus. 8, 16 For example, during the 2013-14 influenza season, A(H3N2) virus clade 3C.2a viruses possessing a new glycosylation site in antigenic site B of HA emerged and predominated among circulating A(H3N2) viruses which led to a low or null vaccine effectiveness for that season. [17] [18] [19] [20] As vaccine effectiveness may not be fully explained by antigenic analysis using the hemagglutinin inhibition (HI) assay, the availability of high-throughput platforms to characterize HA genetic groups, for example, next-generation sequencing (NGS) techniques, can provide more timely information to evaluate protection afforded by vaccination.
Currently, the government of Kenya is considering recommending annual influenza vaccine for young children. 21 As an influenza vaccination program is implemented, there will be a need to establish genetic and antigenic viral surveillance which could be used to assess how well the vaccine performs and inform public health decisions on vaccination strategies. 7 We characterized the genetic changes in A(H3N2) viruses circulating in coastal Kenya using full-length HA sequences generated through next-generation sequencing (NGS) from respiratory specimens collected from inpatient and outpatient sentinel surveillance sites in coastal Kenya from 2009 to 2017.
| ME THODS

| Sample sources and molecular screening
The samples used in this study were collected from health facilities within the Kilifi Health and Demographic Surveillance System (KHDSS) on the coast of Kenya. 22 Non-residents and residents of KHDSS presenting to these facilities were included. First, 5304 nasopharyngeal/oropharyngeal (NP/OP) swabs were taken from childhood admissions under the age of 5 years with syndromic severe or very severe pneumonia 23 collected as part of continuous viral pneumonia surveillance at the Kilifi County Referral Hospital (KCH) from January 2009 through December 2016. 23 Second, 6254 NP swab samples were taken from outpatients of all ages presenting with acute respiratory illness to selected nine outpatient health facilities spread throughout the KHDSS between December 2015 and March 2017. A comprehensive description of the study area and respiratory disease surveillance at KCH and surrounding outpatient health facilities is available from previous reports. [22] [23] [24] [25] Samples were stored in viral transport medium (VTM) at −80°C prior to molecular screening and subsequent processing. 24, 26, 27 Samples were screened for a range of respiratory viruses, including IAV, using a multiplex (MPX) reverse transcription (RT)-PCR assay employing Qiagen QuantiFast multiplex RT-PCR kit (Qiagen), 26 with epidemiological surveillance results for the period 2007-12 previously reported. 24 A real-time PCR cycle threshold (Ct) of <35.0 was used to define virus-positive samples. 26 
| RNA extraction and multi-segment real-time polymerase chain reaction
| Next-generation sequencing (NGS) of influenza A virus
| Bioinformatic analysis
Contiguous nucleotide sequence (contigs) assembly was carried out using the FLU module of the Iterative Refinement Meta-Assembler (IRMA), 29 which performs iterative segment-level read sorting based on Lineage Assignment By Extended Learning (LABEL), 30 and iteratively refines the references to optimize the final assembly based on the Striped Smith-Waterman (SSW) algorithm. 31 
| Phylogenetic analysis
Consensus nucleotide sequences of HA gene were aligned and translated into amino acids using MUSCLE program implemented in mega v7.0.26. 33 The sequences of reference strains of known clades and Northern Hemisphere vaccine strains recommended by WHO included in the phylogenetic analysis were obtained from the GISAID EpiFlu ™ database (https ://www.gisaid.org/). Phylogenetic trees were constructed with maximum likelihood (ML) and bootstrap analysis of 1000 replicates using the GTR + G model implemented in mega 7.0.26. The full-length HA sequences were used to characterize A(H3N2) strains into genetic clades and subclades according to ECDC guidelines. 34, 35 
| Prediction of potential glycosylation sites
Potential N-linked glycosylation sites on the HA were determined using the NetNGlyc 1.0 server (http://www.cbs.dtu.dk/servi ces/ NetNG lyc/), in which a threshold of >0.5 suggests glycosylation.
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| RE SULTS
| Direct sequencing of IAV from clinical specimens using NGS
The specimen processing flow for IAV NGS is shown in Figure 1 
| Analysis of A(H3N2) virus HA gene sequences
We investigated the HA gene sequences to characterize the amino The receptor-binding site of A(H3N2) virus is highly conserved at amino acids positions 98, 136, 153, 183, 190, 194, 195 , and 228 on HA1. However, we did not observe any substitution in these conserved positions in the Kilifi strains.
| D ISCUSS I ON
In this study, we characterized the circulating A(H3N2) viruses in in Cameroon 36 and Mozambique, 37 and in Asia, for example, in
Thailand. 38 Thus, the continuing evolution of A(H3N2) in Kilifi is in duced VE for A (H3N2) viruses and has been described previously. 18 The substitution arose during the 2013-14 influenza season, and viruses with the substitution predominated among circulating A(H3N2)
viruses. 17 Taken together, these variations underscore the rapid evo- 
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